Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (561-570 of 609) with videos related to

Pageof 61
Sort By:
Tropical Medicine and Infectious Disease|June 27, 2023
Is the Pharmacokinetics of First-Line Anti-TB Drugs a Cause of High Mortality Rates in TB Patients Admitted to the ICU? A Non-Compartmental Pharmacokinetic AnalysisFrancisco Beraldi-Magalhaes, Suzanne L Parker, Cristina Sanches, et al.
Therapeutic Drug Monitoring|April 19, 2023
Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods StudyErin F Barreto, Pooja N Chitre, Kathleen H Pine, et al.
Infection|October 14, 2025
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patientsMy-Luong Vuong, Omar Elkayal, Ruth Van Daele, et al.
Clinical Pharmacokinetics|April 22, 2025
Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19Darren M Roberts, Xin Liu, Suzanne L Parker, et al.
Intensive Care Medicine|February 2, 2022
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trialStefan Hagel, Friedhelm Bach, Thorsten Brenner, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 13, 2019
A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING IIIJeffrey Lipman, Stephen J Brett, Jan J De Waele, et al.
Clinical Pharmacokinetics|July 30, 2020
Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial AgentsMarkus Zeitlinger, Birgit C P Koch, Roger Bruggemann, et al.
Clinical Pharmacokinetics|January 19, 2019
Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing RecommendationsPieter J Colin, Karel Allegaert, Alison H Thomson, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2022
Optimizing Meropenem in Highly Resistant Klebsiella pneumoniae Environments: Population Pharmacokinetics and Dosing Simulations in Critically Ill PatientsAnh Quan Truong, Xuan Co Dao, Dinh Hoa Vu, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO studyEmmanuel Novy, Mohd H Abdul-Aziz, Vesa Cheng, et al.
Pageof 61

Showing results (561-570 of 609) with videos related to

Sort By:
Pageof 61
Tropical Medicine and Infectious Disease|June 27, 2023
Is the Pharmacokinetics of First-Line Anti-TB Drugs a Cause of High Mortality Rates in TB Patients Admitted to the ICU? A Non-Compartmental Pharmacokinetic AnalysisFrancisco Beraldi-Magalhaes, Suzanne L Parker, Cristina Sanches, et al.
Therapeutic Drug Monitoring|April 19, 2023
Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods StudyErin F Barreto, Pooja N Chitre, Kathleen H Pine, et al.
Infection|October 14, 2025
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patientsMy-Luong Vuong, Omar Elkayal, Ruth Van Daele, et al.
Clinical Pharmacokinetics|April 22, 2025
Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19Darren M Roberts, Xin Liu, Suzanne L Parker, et al.
Intensive Care Medicine|February 2, 2022
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trialStefan Hagel, Friedhelm Bach, Thorsten Brenner, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 13, 2019
A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING IIIJeffrey Lipman, Stephen J Brett, Jan J De Waele, et al.
Clinical Pharmacokinetics|July 30, 2020
Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial AgentsMarkus Zeitlinger, Birgit C P Koch, Roger Bruggemann, et al.
Clinical Pharmacokinetics|January 19, 2019
Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing RecommendationsPieter J Colin, Karel Allegaert, Alison H Thomson, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2022
Optimizing Meropenem in Highly Resistant Klebsiella pneumoniae Environments: Population Pharmacokinetics and Dosing Simulations in Critically Ill PatientsAnh Quan Truong, Xuan Co Dao, Dinh Hoa Vu, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO studyEmmanuel Novy, Mohd H Abdul-Aziz, Vesa Cheng, et al.
Pageof 61